Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Investigating alpha‐synuclein co‐pathology in Alzheimer's disease by means of cerebrospinal fluid alpha‐synuclein seed amplification assay
G. Bellomo, Andrea Toja, Federico Paolini Paoletti, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 4, pp. 2444-2452
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

The Common Alzheimer's Disease Research Ontology (CADRO) for biomarker categorization
Amanda M. Leisgang Osse, Jefferson W. Kinney, Jeffrey L. Cummings
Alzheimer s & Dementia Translational Research & Clinical Interventions (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 2
Clinical and diagnostic implications of Alzheimer’s disease copathology in Lewy body disease
Lorenzo Barba, Samir Abu‐Rumeileh, Henryk Barthel, et al.
Brain (2024) Vol. 147, Iss. 10, pp. 3325-3343
Closed Access | Times Cited: 10
CSF α-Synuclein Seed Amplification Assay in Patients With Atypical Parkinsonian Disorders
Chloe Anastassiadis, Iván Martínez-Valbuena, Anna Vasilevskaya, et al.
Neurology (2024) Vol. 103, Iss. 6
Closed Access | Times Cited: 10
Toward alpha‐synuclein seed amplification assay in clinical practice
Mathieu Verdurand, Flora Kaczorowski, Sophie Dautricourt, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Toward a biological definition of neuronal and glial synucleinopathies
Claudio Soto, Brit Mollenhauer, Oskar Hansson, et al.
Nature Medicine (2025)
Closed Access | Times Cited: 1
Evidence for alpha-synuclein aggregation in older individuals with hyposmia: a cross-sectional study
Kenneth Marek, David Russell, Luis Concha‐Marambio, et al.
EBioMedicine (2025) Vol. 112, pp. 105567-105567
Open Access | Times Cited: 1
Alpha synuclein co-pathology is associated with accelerated amyloid-driven tau accumulation in Alzheimer’s disease
Nicolai Franzmeier, Sebastian Niclas Roemer, Alexander Bernhardt, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Biological effects of pathologies in Lewy body diseases: why timing matters
Elie Matar, Glenda M. Halliday
The Lancet Neurology (2025) Vol. 24, Iss. 5, pp. 441-455
Closed Access | Times Cited: 1
In vivo detection of Alzheimer's and Lewy body disease concurrence: Clinical implications and future perspectives
Simone Baiardi, Oskar Hansson, Johannes Levin, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 8, pp. 5757-5770
Open Access | Times Cited: 7
Evaluation of Cerebrospinal Fluid α‐Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal Syndrome
David Vaughan, Riona Fumi, Marte Theilmann Jensen, et al.
Movement Disorders (2024)
Open Access | Times Cited: 7
Biomarker‐Based Approach to α‐Synucleinopathies: Lessons from Neuropathology
Gábor G. Kovács, Lea T. Grinberg, Glenda M. Halliday, et al.
Movement Disorders (2024)
Open Access | Times Cited: 4
Protein misfolding: understanding biology to classify and treat synucleinopathies
Tiago F. Outeiro, Günter U. Höglinger, Anthony E. Lang, et al.
Journal of Neural Transmission (2025)
Open Access
Anosmia and Upper Limb Rigidity—A Potential Phenotype of Idiopathic Normal Pressure Hydrocephalus with Cerebrospinal Fluid α‐Synuclein Seeds
Sandrina Weber, Carly M. Farris, Yihua Ma, et al.
Movement Disorders (2025)
Open Access
Characterizing visual read tau‐PET‐negative participants with Alzheimer's disease dementia
Roos M. Rikken, Emma M. Coomans, Lotte A. de Koning, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 4
Open Access
Novel CSF β-synuclein-specific assays signal early synaptic degeneration in Alzheimer’s disease
Sherif Bayoumy, Julie Goossens, Charlotte De Rocker, et al.
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access
Biological definitions of synucleinopathies should be anchored in clinical trajectories and encompass the complex biology of the disease
David Bendetowicz, Vincent Planche, Erwan Bézard, et al.
Journal of Parkinson s Disease (2025)
Open Access
CSF α-synuclein aggregation is associated with APOE ε4 and progressive cognitive decline in Alzheimer's disease
Qiang Qiang, Loren Skudder‐Hill, Tomoko Toyota, et al.
Neurobiology of Aging (2025)
Closed Access
Atrophy trajectories in Alzheimer’s disease: how sex matters
Anna Inguanzo, Konstantinos Poulakis, Javier Oltra, et al.
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access
Plasma proteome profiling identified biomarkers for the differential diagnosis and molecular staging of neurodegenerative dementias
G. Bellomo, Lisa Vermunt, Sjors G. J. G. In ‘t Veld, et al.
Research Square (Research Square) (2025)
Closed Access
Inborn errors of canonical autophagy in neurodegenerative diseases
Dennis Freisem, Helene Hoenigsperger, Alberto Catanese, et al.
Human Molecular Genetics (2025)
Open Access
Influence of co-pathology on CSF and plasma synaptic markers SNAP25 and VAMP2 in Alzheimer’s disease and Parkinson’s disease
Lorenzo Gaetani, G. Bellomo, Davide Chiasserini, et al.
Research Square (Research Square) (2025)
Closed Access
Misfolded α‐synuclein co‐occurrence with Alzheimer's disease proteinopathy
Erin M. Jonaitis, Karen MacLeod, Jennifer Lamoureux, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 5
Open Access
α-Synuclein seeding amplification assays for diagnosing synucleinopathies: an innovative tool in clinical implementation
Yaoyun Kuang, Hengxu Mao, Xiaoyun Huang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Association of CSF α-Synuclein Seed Amplification Assay Positivity with Disease Progression and Cognitive Decline: A Longitudinal Alzheimer's Disease Neuroimaging Initiative Study
Duygu Tosun, Zachary Hausle, Pamela Thropp, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top